Research Article

Production of Silver Nanoparticles with Strong and Stable Antimicrobial Activity against Highly Pathogenic and Multidrug Resistant Bacteria

Table 2

The 3 selected isolates SHE, S11P and S5, response to the produced nano particles and drug of choice against ATCC bacterial strains according to zone inhibition in millimeter.

Tested pathogenic strainTested antimicrobial agents
CRODACNSN

Isolate SHE AgNPs
S. aureus 2025NT16
S. epidermidis 3030NT17
P. aeruginosa NTNT1914
E. coli 29NZINT11
K. pneumoniae 29NZINT19

Isolate S11P AgNPs
S. aureus 2223NT12
S. epidermidis 3.23NT1.3
P. aeruginosa NTNT1915
E. coli 28NZINT10
K. pneumoniae 24NZINT14

Isolate S5 AgNPs
S. aureus 2025NT12
S. epidermidis 323NT11
P. aeruginosa NTNT1913
E. coli 29NZINT10
K. pneumoniae 29NZINT15

NT: not tested; NZI: no zone of inhibition was observed; CRO: ceftriaxone; DA: clindamycin; CN: gentamicin; SN: silver nanoparticles.